Creoptix Overview
- Year Founded
-
2009

- Status
-
Acquired/Merged
- Employees
-
31

- Latest Deal Type
-
M&A
Creoptix General Information
Description
Developer of biosensors designed to accelerate discovery by providing cutting-edge tools for molecular interaction analysis. The company's biosensors focus on next-generation bioanalytical instruments for drug discovery and life sciences for both industry and academic research, enabling life science researchers to benefit from versatile carboxyl-coupling for a range of molecules and software, which integrates assay setup and data evaluation in one tool.
Contact Information
Website
www.creoptix.comCorporate Office
- Zugerstrasse 76
- 8820 Wadenswil
- Switzerland
Corporate Office
- Zugerstrasse 76
- 8820 Wadenswil
- Switzerland
Creoptix Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Merger/Acquisition | 07-Jan-2022 | Completed | Generating Revenue | |||
4. Later Stage VC (Series C) | 30-Sep-2019 | Completed | Generating Revenue | |||
3. Later Stage VC (Series B) | 26-Jul-2017 | Completed | Generating Revenue | |||
2. Early Stage VC (Series A) | 20-Nov-2013 | $3.3M | $3.3M | Completed | Generating Revenue | |
1. Accelerator/Incubator | Completed | Generating Revenue |
Creoptix Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | ||||||||
Series C | ||||||||
Preferred A | ||||||||
Preferred Shares | ||||||||
Preferred Shares | 4,338 | $2.53 | $2.53 | 1x | $2.53 | 0.68% | ||
Ordinary Shares | 53,502 | $22.73 | $22.73 | 1x | $22.73 | 8.35% |
Creoptix Comparisons
Industry
Financing
Details
Creoptix Competitors (9)
One of Creoptix’s 9 competitors is SPT Labtech, a Private Equity-Backed company based in Melbourn, United Kingdom.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
SPT Labtech | Private Equity-Backed | Melbourn, United Kingdom | ||||
Unchained Labs | Private Equity-Backed | Pleasanton, CA | ||||
Nanion Technologies | Accelerator/Incubator Backed | Munich, Germany | ||||
Standard BioTools | Formerly VC-backed | San Francisco, CA | ||||
Carterra | Venture Capital-Backed | Salt Lake City, UT |
Creoptix Patents
Creoptix Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4172625-A1 | A method for determining kinetic parameters of a reaction | Active | 26-Jun-2020 | ||
JP-2023531046-A | Methods for determining kinetic parameters of reaction | Active | 26-Jun-2020 | ||
US-20230273202-A1 | A method for determining kinetic parameters of a reaction | Pending | 26-Jun-2020 | ||
EP-4172625-B1 | A method for determining kinetic parameters of a reaction | Active | 26-Jun-2020 | ||
JP-7672436-B2 | Methods for determining the kinetic parameters of a reaction | Active | 26-Jun-2020 | G01N33/557 |
Creoptix Signals
Creoptix Former Investors (12)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Aargauische Kantonalbank | Corporation | Minority | ||
EFI Lake Geneva Ventures | Venture Capital | Minority | ||
EuroUS Ventures | Venture Capital | Minority | ||
Fongit Seed Invest | Venture Capital | Minority | ||
Massachusetts Biomedical Initiatives | Accelerator/Incubator |
Creoptix FAQs
-
When was Creoptix founded?
Creoptix was founded in 2009.
-
Where is Creoptix headquartered?
Creoptix is headquartered in Wadenswil, Switzerland.
-
What is the size of Creoptix?
Creoptix has 31 total employees.
-
What industry is Creoptix in?
Creoptix’s primary industry is Discovery Tools (Healthcare).
-
Is Creoptix a private or public company?
Creoptix is a Private company.
-
What is Creoptix’s current revenue?
The current revenue for Creoptix is
. -
How much funding has Creoptix raised over time?
Creoptix has raised $12.8M.
-
Who are Creoptix’s investors?
Aargauische Kantonalbank, EFI Lake Geneva Ventures, EuroUS Ventures, Fongit Seed Invest, and Massachusetts Biomedical Initiatives are 5 of 12 investors who have invested in Creoptix.
-
Who are Creoptix’s competitors?
SPT Labtech, Unchained Labs, Nanion Technologies, Standard BioTools, and Carterra are some of the 9 competitors of Creoptix.
-
When was Creoptix acquired?
Creoptix was acquired on 07-Jan-2022.
-
Who acquired Creoptix?
Creoptix was acquired by Malvern Panalytical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »